Skip to main content
TipRanks
Go Ultimate75% OFF

Medigen Biotechnology Corporation (3176) Balance Sheet

Medigen Biotechnology Corporation Balance Sheet

Medigen Biotechnology Corporation's total assets for Q2 2026 were NT$6.90B, a decrease of 0.66% from the previous quarter. TW:3176 total liabilities were NT$2.19B for the fiscal quarter, a 1.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 6.18BNT$ 6.71BNT$ 8.53BNT$ 9.98BNT$ 8.20B
NT$ 1.46BNT$ 1.67BNT$ 3.53BNT$ 3.51BNT$ 1.77B
NT$ 4.72BNT$ 5.04BNT$ 5.00BNT$ 6.47BNT$ 6.43B

Currency in TWD

Medigen Biotechnology Corporation Liabilities to Assets

04B8B12B20 %30 %40 %50 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets